Smith KL, Zhao F, Mayer IA, Tevaarwerk AJ, et al. Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131. Cancer 2024 Jan 18. doi: 10.1002/cncr.35187.
PMID: 38236702